
120 Alphawave IP Group plc | Annual report and financial statements 2021
2 Accounting policies continued
Revenue recognition continued
IP products
The Group’s IP products are typically licensed under
standard pay-per-use licence agreements and are
delivered over the period its customers are developing their
semiconductor products, which can span several years.
The Group categorises its standard pay-per-use licences
into three types: derivative, migration and R&D:
• derivative licences are utilised when the licensed IP
is derived from an existing IP already developed for a
specific foundry manufacturing node;
• migration licences are utilised when there is a
requirement to migrate existing IP products to new
foundry manufacturing nodes; and
• R&D licences are utilised for new IP products, depending
on the level of complexity, that are being developed.
Due to the complexity of the IP products being delivered
and the need for customers to integrate the IP products with
other IP building blocks in their chip designs, the Group’s
IP products are typically delivered in multiple stages,
referred to as IP views, all of which require some level of
customisation and/or configuration. The delivery of these IP
views occurs over the development phase of the customers’
chip design.
Although delivery of the licensed IP products is split over
multiple deliveries of IP views, each of these deliveries is
not considered distinct as each IP view is highly dependent
on or interrelated with one or more of the other IP views,
as each successive IP view is based on the prior views of
that IP product. Therefore, each IP view is not separately
identifiable from other IP views of the same IP product and
hence they are considered part of the same performance
obligation, being the transfer of the IP product and
associated deliverables to final specification. Further, where
a contract contains multiple IP products and non-recurring
engineering (NRE) work, these products and any NRE
required to deliver them are considered to be a single
performance obligation and not distinct from each other
as customers are unable to benefit from the IP products
on their own or together with other readily available
resources, due to the bespoke nature of the configuration
that the Group performs on the IP products as part of the
licence arrangements. Support is considered a separate
performance obligation from the transfer of the IP product,
as customers can benefit from the service with other
resources that are readily available to them and the Group’s
promise to transfer the service is separately identifiable
from other performance obligations in the contract.
Each contract to license the Group’s IP products includes
pricing to be paid by the customer, based on the specific
IP products licensed and the amount of any NRE required.
Contracts do not typically permit refunds and payment
terms often align with delivery of the IP views and final
silicon acceptance and are within the contract milestones,
and as such, there is no financing element associated with
the contractual payment terms. Payment terms are based
on completion of milestones throughout the project life for
fixed price contracts and payment is generally due within
30days of receipt of invoice. In one instance we offered
credit terms to a customer on which a commercial rate of
interest was charged.
Any major modifications to the contract or IP product
specification will typically result in a new contract being
signed with the customer for the additional work. In
assessing whether a contract modification should be
accounted for as part of the original contract or as a
separate contract, the Group considers the following:
• whether the contract modification is ‘accepted’, i.e. it
creates legally enforceable rights and obligations on the
parties to the contract;
• if the contract modification is accepted, whether it adds
distinct goods or services that are priced commensurate
with stand-alone selling prices; and
• if the contract modification does not add distinct goods or
services that are priced commensurate with stand-alone
selling prices, whether the remaining goods or services
are distinct from those already transferred.
If the contract modification is not accepted, it is accounted
for as part of the original contract until such point that
it is accepted. If the contract modification is accepted
and it adds distinct goods or services that are priced
commensurate with stand-alone selling prices, it is
accounted for as a separate contract. If the contract
modification is accepted and it does not add distinct
goodsor services that are priced commensurate with
stand-alone selling prices, and the remaining goods or
services are distinct from those already transferred, it is
accounted for as termination of the existing contract and
creation of a new contract. If the contract modification is
accepted and it does not add distinct goods or services that
are priced commensurate with stand-alone selling prices,
and the remaining goods or services are not distinct from
those already transferred, it is accounted for as part of the
originalcontract.
The contract price is allocated to the support performance
obligation based on its relative standalone selling price
and the Group uses the residual method to allocate the
remaining contract price to the IP product performance
obligation. The contract price allocated to the IP products is
recognised as the IP products are delivered to the customer.
Notes to the consolidated financial statements continued
for the year ended 31 December 2021